Which is not true regarding Insulinoma :
**Core Concept**
Insulinoma is a rare tumor of the pancreas that produces excess insulin, leading to hypoglycemia (low blood sugar). It is typically a benign tumor, but its management requires careful consideration of the potential risks and benefits of surgical, medical, and metabolic interventions.
**Why the Correct Answer is Right**
Insulinomas are usually solitary, benign tumors that arise from the beta cells of the pancreas. They are often diagnosed in individuals with a strong family history of similar tumors, suggesting a possible genetic predisposition. The characteristic presentation of insulinoma is hypoglycemia, which can be confirmed by a glucose tolerance test or a fasting glucose test. The symptoms of hypoglycemia can range from mild to severe and may include confusion, dizziness, and loss of consciousness.
**Why Each Wrong Option is Incorrect**
**Option A:** Insulinomas are typically solitary tumors. This is true, as most insulinomas are solitary lesions rather than multiple or diffuse pancreatic tumors.
**Option B:** Insulinomas can be managed with diazoxide, a medication that inhibits insulin release. This is true, as diazoxide is sometimes used to manage symptomatic hypoglycemia in patients with insulinoma.
**Option C:** Insulinomas are not typically associated with autoimmune disorders. This is not true, as some insulinomas are associated with autoimmune disorders, such as type 1 diabetes mellitus.
**Clinical Pearl / High-Yield Fact**
When managing patients with insulinoma, it is essential to consider the potential risks and benefits of surgical intervention, including the possibility of postoperative hypoglycemia and the risk of recurrence.
**Correct Answer: C. Insulinomas are not typically associated with autoimmune disorders.